Difficulty walking with MS is not just about physical limitations, but also emotions, stigma, and how others respond, a ...

Selma Blair, 53, gave an inspirational update on ‘TODAY with Jenna & Shenielle’ about her multiple sclerosis as she returns ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed. A new artificial intelligence ...

The blogger Trevis Gleason shares how multiple sclerosis has triggered sensory symptoms like the "wet spot" and "trickling" sensations. Learn how he adapts to and manages these unusual experiences.

A  systematic review from Murdoch University in Western Australia has analysed the lived walking experience of people living with multiple sclerosis (MS). The study found that for many people with MS, ...

IU quarterback Fernando Mendoza thanked his mother in his Heisman Trophy acceptance speech. Here's what you should know about ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why. Researchers found that inflammation in the brain disrupts the energy supply of ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been able to identify two biologically distinct types of multiple sclerosis (MS), ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS). The research, published in the journal Environmental International, discovered that ...

Multiple sclerosis (MS) is a disorder that prompts the body's immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic nerve and spinal cord. This can in turn ...

Shares drop after FDA delays decision on tolebrutinib drug Late-stage trial shows drug fails to slow disability progression Analysts fret over Sanofi drug pipeline and investor confidence Dec 15 ...